Skip to content

Eyerising International

Request correction

Corporate brand

Unclaimed

An Australian MedTech company advancing repeated low-level red-light (RLRL) therapy for childhood myopia management.

Last updated September 2, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Eyerising International is an Australian medical technology company dedicated to advancing repeated low-level red-light (RLRL) therapy for childhood myopia management across the globe. The company was co-founded by Professor Mingguang He and Jason Sun, and is based in Melbourne, Australia. Its patented technology is registered on the Australian Register of Therapeutic Goods (ARTG 412752) and operates across more than 40 countries.

History

Eyerising International was established in Melbourne, Australia, with the mission of bringing RLRL therapy to families worldwide. It was co-founded by Professor Mingguang He and Jason Sun. The company achieved CE marking for European markets and registered its device on the Australian Register of Therapeutic Goods (ARTG 412752).

Products and positioning

  • Eyerising Myopia Management Device

    A home-use medical device indicated for myopia control, available only through optometrists and ophthalmologists. It uses patented repeated low-level red-light (RLRL) technology to emit visible red light from a laser diode, delivered to the back of the eye to slow myopia progression by slowing the elongation of the eye.

Sources4 sources

Cite this profile: Cite the canonical profile. /brand-wiki/eyerising-international · Editorial policy · How profiles are compiled